Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Maintenance of supersaturation II: indomethacin crystal growth kinetics versus degree of supersaturation.

Patel DD, Anderson BD.

J Pharm Sci. 2013 May;102(5):1544-53. doi: 10.1002/jps.23498. Epub 2013 Mar 11.

PMID:
23494835
[PubMed - indexed for MEDLINE]
2.

Maintenance of supersaturation I: indomethacin crystal growth kinetic modeling using an online second-derivative ultraviolet spectroscopic method.

Patel DD, Joguparthi V, Wang Z, Anderson BD.

J Pharm Sci. 2011 Jul;100(7):2623-41. doi: 10.1002/jps.22478. Epub 2011 Jan 21.

PMID:
21259238
[PubMed - indexed for MEDLINE]
3.

Effect of precipitation inhibitors on indomethacin supersaturation maintenance: mechanisms and modeling.

Patel DD, Anderson BD.

Mol Pharm. 2014 May 5;11(5):1489-99. doi: 10.1021/mp400658k. Epub 2014 Apr 7.

PMID:
24654924
[PubMed - in process]
4.

Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.

Xiang TX, Anderson BD.

J Pharm Sci. 2013 Mar;102(3):876-91. doi: 10.1002/jps.23353. Epub 2012 Dec 20.

PMID:
23280486
[PubMed - indexed for MEDLINE]
5.

Crystal growth kinetics of theophylline monohydrate.

Rodríguez-Hornedo N, Wu HJ.

Pharm Res. 1991 May;8(5):643-8.

PMID:
1866380
[PubMed - indexed for MEDLINE]
6.

Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.

Sun DD, Ju TC, Lee PI.

Eur J Pharm Biopharm. 2012 May;81(1):149-58. doi: 10.1016/j.ejpb.2011.12.016. Epub 2012 Jan 2.

PMID:
22233548
[PubMed - indexed for MEDLINE]
7.

Dissolution studies of physical mixtures of indomethacin with alpha- and gamma-cyclodextrins.

Vranić E, Uzunović A.

Bosn J Basic Med Sci. 2010 Aug;10(3):197-203.

PMID:
20846125
[PubMed - indexed for MEDLINE]
8.

Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs.

Ozaki S, Kushida I, Yamashita T, Hasebe T, Shirai O, Kano K.

J Pharm Sci. 2013 Jul;102(7):2273-81. doi: 10.1002/jps.23588. Epub 2013 May 8.

PMID:
23658029
[PubMed - indexed for MEDLINE]
9.

The kinetics of formation and dissolution of uric acid crystals.

Lam CY, Nancollas GH, Ko SJ.

Invest Urol. 1978 May;15(6):473-7.

PMID:
649297
[PubMed - indexed for MEDLINE]
10.

Light-scattering investigations of nucleation processes and kinetics of crystallization in macromolecular systems.

Malkin AJ, McPherson A.

Acta Crystallogr D Biol Crystallogr. 1994 Jul 1;50(Pt 4):385-95.

PMID:
15299390
[PubMed]
11.

Heterogeneous nucleation and growth of calcium carbonate on calcite and quartz.

Lioliou MG, Paraskeva CA, Koutsoukos PG, Payatakes AC.

J Colloid Interface Sci. 2007 Apr 15;308(2):421-8. Epub 2007 Jan 25.

PMID:
17258223
[PubMed]
12.

Characteristics of indomethacin-saccharin (IMC-SAC) co-crystals prepared by an anti-solvent crystallization process.

Chun NH, Wang IC, Lee MJ, Jung YT, Lee S, Kim WS, Choi GJ.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):854-61. doi: 10.1016/j.ejpb.2013.02.007. Epub 2013 Feb 27.

PMID:
23454054
[PubMed - indexed for MEDLINE]
13.

Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution.

Iohara D, Hirayama F, Ishiguro T, Arima H, Uekama K.

Int J Pharm. 2008 Apr 16;354(1-2):70-6. Epub 2007 Nov 17.

PMID:
18093762
[PubMed - indexed for MEDLINE]
14.

Evolution of supersaturation of amorphous pharmaceuticals: the effect of rate of supersaturation generation.

Sun DD, Lee PI.

Mol Pharm. 2013 Nov 4;10(11):4330-46. doi: 10.1021/mp400439q. Epub 2013 Oct 14.

PMID:
24066837
[PubMed - indexed for MEDLINE]
15.

Surface crystallization of indomethacin below Tg.

Wu T, Yu L.

Pharm Res. 2006 Oct;23(10):2350-5. Epub 2006 Aug 23.

PMID:
16927184
[PubMed - indexed for MEDLINE]
16.

Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.

Basavoju S, Boström D, Velaga SP.

Pharm Res. 2008 Mar;25(3):530-41. Epub 2007 Aug 17.

PMID:
17703346
[PubMed - indexed for MEDLINE]
17.

Encapsulation and sustained release of a model drug, indomethacin, using CO(2)-based microencapsulation.

Liu H, Finn N, Yates MZ.

Langmuir. 2005 Jan 4;21(1):379-85.

PMID:
15620328
[PubMed - indexed for MEDLINE]
18.

Protein crystal growth. Growth kinetics for tetragonal lysozyme crystals.

Pusey ML, Snyder RS, Naumann R.

J Biol Chem. 1986 May 15;261(14):6524-9.

PMID:
3700405
[PubMed - indexed for MEDLINE]
Free Article
19.

Effects of sorbed water on the crystallization of indomethacin from the amorphous state.

Andronis V, Yoshioka M, Zografi G.

J Pharm Sci. 1997 Mar;86(3):346-51.

PMID:
9050804
[PubMed - indexed for MEDLINE]
20.

Surface treatment of indomethacin agglomerates with eudragit.

Bajdik J, Pintye-Hódi K, Planinsek O, Tüske Z, Tasic L, Regdon G Jr, Srcic S, Eros I.

Drug Dev Ind Pharm. 2004 Apr;30(4):381-8.

PMID:
15132180
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk